FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016141372> ?p ?o ?g. }

• W2016141372 endingPage "522" @default.
• W2016141372 startingPage "518" @default.
• W2016141372 abstract "Esthesioneuroblastoma is a malignant tumor, arising in the upper nasal cavity, that could spread to the frontal lobe of the brain as well as metastasize to the lymph nodes. Due to the low incidence of this tumor, FDA-approved treatment modalities do not exist and clinical trials have not been performed. We present an interesting case of a 66-year-old female, diagnosed with Kadish stage B esthesioneuroblastoma and stage IIA nonsmall cell carcinoma of the lung, who benefited from our treatment. Both malignancies were diagnosed in 2002 at which time the patient consented to undergo left upper lobectomy for her lung cancer, but she refused the craniofacial resection and radiation therapy recommended for treatment of her esthesioneuroblastoma. From 2003 to 2004 she received treatment at the Burzynski Clinic with oral sodium phenylbutyrate (0.2 g/kg/day). She tolerated the treatment very well without significant adverse events. Gradual reduction in her tumor size was confirmed by repeat MRIs. From treatment start in March 2003 to December 2003 her tumor decreased by 40%. Subsequent MRI from March 2004 revealed increased tumor size, which, however, was still a 13% reduction from the baseline MRI. What is important to mention is that in addition to shrinkage of the esthesioneuroblastoma, the patient obtained the clinical benefit of 3.5-years longer survival than was predicted for her lung cancer—whereas the median survival for a patient with stage IIA adenocarcinoma of the left upper lobe of the lung is approximately two years, our patient survived more than five and a half years. The effect of phenylbutyrate (PB) and its metabolite phenylacetate on neuroblastoma and lung cancer is documented by numerous preclinical studies and is also evident in this case. It is proposed that the activity of these two compounds is mediated through increased expression of the p21 tumor suppressor gene. p21 is a strong inhibitor of cyclin-D and cyclin-dependent kinase 4, which contribute to undifferentiated phenotype in neuroblastoma and are instrumental in cell cycle progression from G1 to S phase. It is hoped that future research and combination of PB with other chemotherapeutic and targeted agents will provide better control of esthesioneuroblastoma and lung cancer." @default.
• W2016141372 created "2016-06-24" @default.
• W2016141372 creator A5060113765 @default.
• W2016141372 creator A5060556267 @default.
• W2016141372 date "2011-01-01" @default.
• W2016141372 modified "2023-10-17" @default.
• W2016141372 title "Treatment of Esthesioneuroblastoma and Nonsmall Cell Lung Cancer with Phenylbutyrate" @default.
• W2016141372 cites W1965923175 @default.
• W2016141372 cites W2004481469 @default.
• W2016141372 cites W2011491826 @default.
• W2016141372 cites W2033939771 @default.
• W2016141372 cites W2069522180 @default.
• W2016141372 cites W2076735667 @default.
• W2016141372 cites W2081147661 @default.
• W2016141372 cites W2086597649 @default.
• W2016141372 cites W2095792231 @default.
• W2016141372 cites W2100128545 @default.
• W2016141372 cites W2109087158 @default.
• W2016141372 cites W2115950918 @default.
• W2016141372 cites W2120450507 @default.
• W2016141372 cites W2122583405 @default.
• W2016141372 cites W2158407216 @default.
• W2016141372 cites W2162734846 @default.
• W2016141372 cites W2315916150 @default.
• W2016141372 cites W2334027844 @default.
• W2016141372 doi "https://doi.org/10.4236/jct.2011.24071" @default.
• W2016141372 hasPublicationYear "2011" @default.
• W2016141372 type Work @default.
• W2016141372 sameAs 2016141372 @default.
• W2016141372 citedByCount "0" @default.
• W2016141372 crossrefType "journal-article" @default.
• W2016141372 hasAuthorship W2016141372A5060113765 @default.
• W2016141372 hasAuthorship W2016141372A5060556267 @default.
• W2016141372 hasBestOaLocation W20161413721 @default.
• W2016141372 hasConcept C121608353 @default.
• W2016141372 hasConcept C126322002 @default.
• W2016141372 hasConcept C141071460 @default.
• W2016141372 hasConcept C143998085 @default.
• W2016141372 hasConcept C146357865 @default.
• W2016141372 hasConcept C151730666 @default.
• W2016141372 hasConcept C2776256026 @default.
• W2016141372 hasConcept C2778801703 @default.
• W2016141372 hasConcept C2781088518 @default.
• W2016141372 hasConcept C509974204 @default.
• W2016141372 hasConcept C71924100 @default.
• W2016141372 hasConcept C86803240 @default.
• W2016141372 hasConceptScore W2016141372C121608353 @default.
• W2016141372 hasConceptScore W2016141372C126322002 @default.
• W2016141372 hasConceptScore W2016141372C141071460 @default.
• W2016141372 hasConceptScore W2016141372C143998085 @default.
• W2016141372 hasConceptScore W2016141372C146357865 @default.
• W2016141372 hasConceptScore W2016141372C151730666 @default.
• W2016141372 hasConceptScore W2016141372C2776256026 @default.
• W2016141372 hasConceptScore W2016141372C2778801703 @default.
• W2016141372 hasConceptScore W2016141372C2781088518 @default.
• W2016141372 hasConceptScore W2016141372C509974204 @default.
• W2016141372 hasConceptScore W2016141372C71924100 @default.
• W2016141372 hasConceptScore W2016141372C86803240 @default.
• W2016141372 hasIssue "04" @default.
• W2016141372 hasLocation W20161413721 @default.
• W2016141372 hasOpenAccess W2016141372 @default.
• W2016141372 hasPrimaryLocation W20161413721 @default.
• W2016141372 hasRelatedWork W1578103067 @default.
• W2016141372 hasRelatedWork W2014363844 @default.
• W2016141372 hasRelatedWork W2277416945 @default.
• W2016141372 hasRelatedWork W2355670240 @default.
• W2016141372 hasRelatedWork W2366917333 @default.
• W2016141372 hasRelatedWork W2386062943 @default.
• W2016141372 hasRelatedWork W2417722035 @default.
• W2016141372 hasRelatedWork W2438375979 @default.
• W2016141372 hasRelatedWork W42275884 @default.
• W2016141372 hasRelatedWork W72554252 @default.
• W2016141372 hasVolume "02" @default.
• W2016141372 isParatext "false" @default.
• W2016141372 isRetracted "false" @default.
• W2016141372 magId "2016141372" @default.
• W2016141372 workType "article" @default.